InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: midastouch017 post# 96

Thursday, 12/30/2010 1:54:13 PM

Thursday, December 30, 2010 1:54:13 PM

Post# of 226
7:00AM Compugen signs $5 million R&D funding agreement in support of its pipeline program (CGEN) 4.80 : Co entered into an agreement with Baize Investments (Israel), under which it will receive $5,000,000 in R&D funding. Under the terms of the funding agreement, which is in support of Compugen's recently announced Pipeline Program, Baize Investments has obtained a financial interest in five designated Compugen-discovered molecules and has been issued a warrant to purchase 500,000 Compugen shares at an exercise price of $6.00 per share, expiring June 30, 2013.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CGEN News